These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 27146520

  • 1. Stability of paclitaxel-loaded solid lipid nanoparticles in the presence of 2-hydoxypropyl-β-cyclodextrin.
    Baek JS, Kim BS, Puri A, Kumar K, Cho CW.
    Arch Pharm Res; 2016 Jun; 39(6):785-93. PubMed ID: 27146520
    [Abstract] [Full Text] [Related]

  • 2. 2-Hydroxypropyl-β-cyclodextrin-modified SLN of paclitaxel for overcoming p-glycoprotein function in multidrug-resistant breast cancer cells.
    Baek JS, Cho CW.
    J Pharm Pharmacol; 2013 Jan; 65(1):72-8. PubMed ID: 23215690
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel delivery.
    Bilensoy E, Gürkaynak O, Doğan AL, Hincal AA.
    Int J Pharm; 2008 Jan 22; 347(1-2):163-70. PubMed ID: 17689901
    [Abstract] [Full Text] [Related]

  • 8. Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer.
    Wang F, Li L, Liu B, Chen Z, Li C.
    Biomed Pharmacother; 2017 Feb 22; 86():595-604. PubMed ID: 28027535
    [Abstract] [Full Text] [Related]

  • 9. Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma.
    Pandey V, Gajbhiye KR, Soni V.
    Drug Deliv; 2015 Feb 22; 22(2):199-205. PubMed ID: 24467582
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Solid lipid nanoparticles of paclitaxel strengthened by hydroxypropyl-β-cyclodextrin as an oral delivery system.
    Baek JS, So JW, Shin SC, Cho CW.
    Int J Mol Med; 2012 Oct 22; 30(4):953-9. PubMed ID: 22859311
    [Abstract] [Full Text] [Related]

  • 14. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery.
    Soga O, van Nostrum CF, Fens M, Rijcken CJ, Schiffelers RM, Storm G, Hennink WE.
    J Control Release; 2005 Mar 21; 103(2):341-53. PubMed ID: 15763618
    [Abstract] [Full Text] [Related]

  • 15. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.
    Danhier F, Lecouturier N, Vroman B, Jérôme C, Marchand-Brynaert J, Feron O, Préat V.
    J Control Release; 2009 Jan 05; 133(1):11-7. PubMed ID: 18950666
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Paclitaxel loaded nanosponges: in-vitro characterization and cytotoxicity study on MCF-7 cell line culture.
    Ansari KA, Torne SJ, Vavia PR, Trotta F, Cavalli R.
    Curr Drug Deliv; 2011 Mar 05; 8(2):194-202. PubMed ID: 21235471
    [Abstract] [Full Text] [Related]

  • 19. Preparation and evaluation of paclitaxel-loaded nanoparticle incorporated with galactose-carrying polymer for hepatocyte targeted delivery.
    Wang Y, Jiang G, Qiu T, Ding F.
    Drug Dev Ind Pharm; 2012 Sep 05; 38(9):1039-46. PubMed ID: 22124381
    [Abstract] [Full Text] [Related]

  • 20. Characterization, pharmacokinetics and disposition of novel nanoscale preparations of paclitaxel.
    Wang C, Wang Y, Wang Y, Fan M, Luo F, Qian Z.
    Int J Pharm; 2011 Jul 29; 414(1-2):251-9. PubMed ID: 21596124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.